Cargando…

Correction to: The impact on renal function after longterm use of anticoagulants in atrial fibrillation patients

Detalles Bibliográficos
Autores principales:	Lee, Wei-Chieh, Lee, Pai-Wei, Wu, Po-Jui, Fang, Yen-Nan, Chen, Huang-Chung, Lin, Yu-Sheng, Fang, Hsiu-Yu, Chang, Shang-Hung, Liu, Ping-Yen, Chen, Mien-Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717660/ https://www.ncbi.nlm.nih.gov/pubmed/34969384 http://dx.doi.org/10.1186/s12959-021-00361-z

Ejemplares similares

The impact on renal function after long-term use of anticoagulants in atrial fibrillation patients
por: Lee, Wei-Chieh, et al.
Publicado: (2021)

Impact of baseline renal function on the efficacy and safety of different Anticoagulants in Atrial Fibrillation Patients – A cohort study
por: Lee, Wei-Chieh, et al.
Publicado: (2022)

Outcomes of catheter ablation vs. medical treatment for atrial fibrillation and heart failure: a meta-analysis
por: Lee, Wei-Chieh, et al.
Publicado: (2023)

Comparing Vitamin K Antagonists and Direct Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement: A Meta-Analysis
por: Lee, Wei-Chieh, et al.
Publicado: (2023)

Efficacy and Safety of Ablation for Symptomatic Atrial Fibrillation in Elderly Patients: A Meta-Analysis
por: Lee, Wei-Chieh, et al.
Publicado: (2021)

Resuming anticoagulation in patients with atrial fibrillation experiencing intracranial hemorrhage
por: Wu, Victor Chien-Chia, et al.
Publicado: (2021)

Different Renal Function Equations and Dosing of Direct Oral Anticoagulants in Atrial Fibrillation
por: Chan, Yi-Hsin, et al.
Publicado: (2022)

Impact of type of oral anticoagulants in patients with cerebral microbleeds after atrial fibrillation-related ischemic stroke or TIA: Results of the NOACISP-LONGTERM registry
por: Wagner, Benjamin, et al.
Publicado: (2022)

Outcomes of Patients with and without Malignancy Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion
por: Shih, Chun-Ting, et al.
Publicado: (2021)

The Relationship of Conduction Disorder and Prognosis in Patients with Acute Coronary Syndrome
por: Lee, Wei-Chieh, et al.
Publicado: (2022)

Major Bleeding Risk in Patients With Non-valvular Atrial Fibrillation Concurrently Taking Direct Oral Anticoagulants and Antidepressants
por: Chang, Kuo-Hsuan, et al.
Publicado: (2022)

Major Bleeding Risk in Atrial Fibrillation Patients Co-Medicated With Non-Vitamin K Oral Anticoagulants and Antipsychotics
por: Chen, Chiung-Mei, et al.
Publicado: (2022)

Impact of Coexisting Risk Factors on Outcomes in Patients with Acute Coronary Syndrome: A Real-World Analysis Using the Taiwan Chang Gung Research Database
por: Lee, Wei-Chieh, et al.
Publicado: (2023)

Anticoagulation in Elderly Patients With Atrial Fibrillation and Renal Dysfunction
por: Cheung, Christopher C., et al.
Publicado: (2023)

LHCb Longterm Plans
por: Parkes, Chris
Publicado: (2017)

Shared decision making for anticoagulation reduces anxiety and improves adherence in patients with atrial fibrillation
por: Chiu, Hsiao-Hui, et al.
Publicado: (2023)

Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014)

Oral anticoagulant use for stroke prevention in atrial fibrillation patients with difficult scenarios
por: Chang, Ting-Yung, et al.
Publicado: (2018)

Optimizing exercise testing‐based risk stratification to predict poor prognosis after acute heart failure
por: Chen, Shyh‐Ming, et al.
Publicado: (2022)

Oral Anticoagulation Timing in Patients with Acute Ischemic Stroke and Atrial Fibrillation
por: Chang, Po-Yin, et al.
Publicado: (2021)

The differences of atrial thrombus locations and variable response to anticoagulation in nonvalvular atrial fibrillation with ventricular cardiomyopathy
por: Zhang, Hao, et al.
Publicado: (2020)

Levosimendan Administration May Provide More Benefit for Survival in Patients with Non-Ischemic Cardiomyopathy Experiencing Acute Decompensated Heart Failure
por: Lee, Wei-Chieh, et al.
Publicado: (2022)

The comparison of efficacy and safety between transradial and transfemoral approach for chronic total occlusions intervention: a meta-analysis
por: Lee, Wei-Chieh, et al.
Publicado: (2022)

Early Levosimendan Administration Improved Weaning Success Rate in Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock
por: Chen, Yu-Wen, et al.
Publicado: (2022)

The beginning of long term longterm
Publicado: (2004)

Longterm endocrine effects of cancer
por: Zacharin, Margaret
Publicado: (2013)

Adherence to a Novel Oral Anticoagulant Among Patients with Atrial Fibrillation
por: Zhou, Meijia, et al.
Publicado: (2015)

Novel oral anticoagulant vs. warfarin in elderly atrial fibrillation patients with normal, mid‐range, and reduced left ventricular ejection fraction
por: Wu, Victor Chien‐Chia, et al.
Publicado: (2020)

Editorial to “The differences of atrial thrombus locations and variable response to anticoagulation in non‐valvular atrial fibrillation with ventricular cardiomyopathy”
por: Chung, Wei‐Hsin, et al.
Publicado: (2020)

Stability of High‐Quality Warfarin Anticoagulation in a Community‐Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
por: Dallalzadeh, Liane O., et al.
Publicado: (2016)

Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease
por: Undas, Anetta
Publicado: (2023)

Cardiovascular outcomes in patients with atrial fibrillation concomitantly treated with antiarrhythmic drugs and non-vitamin k antagonist oral anticoagulants
por: Wu, Victor Chien-Chia, et al.
Publicado: (2023)

The Impact of Complete Revascularization in Symptomatic Severe Left Ventricular Dysfunction between Coronary Artery Bypass Graft and Percutaneous Coronary Intervention
por: Fang, Hsiu-Yu, et al.
Publicado: (2023)

New-Onset Atrial Fibrillation in Patients With Primary Aldosteronism Receiving Different Treatment Strategies: Systematic Review and Pooled Analysis of Three Studies
por: Tsai, Cheng-Hsuan, et al.
Publicado: (2021)

Anticoagulation efficacy of dabigatran etexilate for left atrial appendage thrombus in patients with atrial fibrillation by transthoracic and transesophageal echocardiography
por: Xing, Xiao Fei, et al.
Publicado: (2018)

Atrial fibrillation, electroconvulsive therapy, stroke risk, and anticoagulation
por: Kapadia, Meera, et al.
Publicado: (2023)

Prevalence of oral anticoagulation in atrial fibrillation
por: Bartholomay, Eduardo, et al.
Publicado: (2014)

Anticoagulation in atrial fibrillation: the present and the future
por: Dweck, Marc R, et al.
Publicado: (2012)

Anticoagulation for atrial fibrillation in active cancer
por: Farmakis, Dimitrios, et al.
Publicado: (2022)

Effectiveness and Safety of Non–Vitamin K Antagonist Oral Anticoagulant and Warfarin in Cirrhotic Patients With Nonvalvular Atrial Fibrillation
por: Lee, Hsin‐Fu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0dkbit9q82q97h8ohpv76j5f5m